Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Jon C. Ogg | Jul 17, 2014 at 3:06 PM EDT

4 Key Positive Biotech Stock Catalysts Coming Very Soon

ThinkstockInvestors and speculators often flock to the world biotech for emerging drugs of the future. It is no secret at…

Lee Jackson | Jul 16, 2014 at 10:15 AM EDT

4 Top Biotechs Expected to Beat Earnings Expectations

In a research note, Leerink analysts mentioned four specific top biotech names that may have the ability to beat current…

Paul Ausick | Jul 14, 2014 at 4:24 PM EDT

Why the Exelixis Cancer Trial News Matters This Time

ThinkstockCancer treatment developer Exelixis Inc. (NASDAQ: EXEL) is trading very heavy volume today and getting a sharp price boost following…

Paul Ausick | Jul 14, 2014 at 10:40 AM EDT

Abbott, Mylan Join Forces to Dodge U.S. Taxes

Add one more to the litany of pharmaceutical company mergers that are being made to avoid U.S. taxes. Mylan's existing…

Lee Jackson | Jul 9, 2014 at 8:40 AM EDT

UBS Very Bullish on Biotech Stocks Ahead of Second-Quarter Earnings

In a new research report, UBS analysts are very positive on some top biotech stocks before second-quarter earnings numbers hit…

Jon C. Ogg | Jul 8, 2014 at 11:45 AM EDT

Breakthrough Blood Test in Identifying Alzheimer’s Disease

ThinkstockSometimes there are company reports from non-U.S. companies that are just too important to pass up. That was the case…

Lee Jackson | Jul 8, 2014 at 10:15 AM EDT

Upcoming Catalysts Could Drive Seven Biotech and Health Care Stocks Higher

ThinkstockBinary events are often the key element in moving a biotech or health care stock higher. Negative binary results or…

Trey Thoelcke | Jul 7, 2014 at 11:15 AM EDT

Washington State Issues First Retail Marijuana Licenses

ThinkstockWashington state issued its first retail marijuana licenses on Monday. The state’s Liquor Control Board notified two dozen stores so…

Jon C. Ogg | Jul 2, 2014 at 11:55 AM EDT

MannKind Poll Points to Bias That Stock Will Rise Above $15 into 2015

24/7 Wall St. ran a poll for investors this week on where MannKind shares would go into 2015, and the…

Lee Jackson | Jul 2, 2014 at 9:00 AM EDT

The Path to FDA Approval Could Launch Seven Biotech Stocks Much Higher

A new report from the analysts at Cowen shows that, on average, biotech stocks gained 84% in the 12 months…

Jon C. Ogg | Jun 30, 2014 at 2:30 PM EDT

Poll: Where Does MannKind Stock Go in 2015 After Afrezza Approval?

ThinkstockMannKind Corp. (NASDAQ: MNKD) has seen its shares surge on news that it has finally won U.S. Food & Drug…

Paul Ausick | Jun 30, 2014 at 10:30 AM EDT

Vindication for MannKind on FDA Approval

After markets closed last Friday, MannKind announced that the FDA had approved Afrezza, a rapid-acting, inhaled insulin powder that improves…

Jon C. Ogg | Jun 28, 2014 at 9:40 AM EDT

Two Health Care Stocks With 50% Upside Under Obamacare

ThinkstockThe rise and fall of health care stocks is often hard to grasp, particularly in a world where the health…

Paul Ausick | Jun 27, 2014 at 4:47 PM EDT

MannKind’s Afrezza Inhaled Insulin Drug Gets FDA Approval

ThinkstockThe U.S. Food and Drug Administration (FDA) late Friday afternoon announced that it has approved Afrezza, a rapid-acting, inhaled insulin…

Paul Ausick | Jun 24, 2014 at 1:15 PM EDT

The Real Attraction to Vertex After Cystic Fibrosis Success

Vertex Pharmaceuticals has reported that two Phase 3 studies of its lumacaftor cystic fibrosis drug in combination with its Kalydeco…

1 … 284 285 286 287 288 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

4 Key Positive Biotech Stock Catalysts Coming Very Soon

4 Top Biotechs Expected to Beat Earnings Expectations

Why the Exelixis Cancer Trial News Matters This Time

Abbott, Mylan Join Forces to Dodge U.S. Taxes

UBS Very Bullish on Biotech Stocks Ahead of Second-Quarter Earnings

Breakthrough Blood Test in Identifying Alzheimer’s Disease

Upcoming Catalysts Could Drive Seven Biotech and Health Care Stocks Higher

Washington State Issues First Retail Marijuana Licenses

MannKind Poll Points to Bias That Stock Will Rise Above $15 into 2015

The Path to FDA Approval Could Launch Seven Biotech Stocks Much Higher

Poll: Where Does MannKind Stock Go in 2015 After Afrezza Approval?

Vindication for MannKind on FDA Approval

Two Health Care Stocks With 50% Upside Under Obamacare

MannKind’s Afrezza Inhaled Insulin Drug Gets FDA Approval

The Real Attraction to Vertex After Cystic Fibrosis Success

AGQ’s Backwardation Squeeze Could Trigger a Delivery Default That Whipsaws Silver

Monroe Merger Closes, but Dividend Cut Signals Deeper Trouble Ahead

Ditch Starbucks and DoorDash, George Kamel Says. How Cheap Appliances Can Replace Your Takeout Budget

Ditch Starbucks and DoorDash, George Kamel Says. How Cheap Appliances Can Replace Your Takeout Budget

39% of Americans Are Betting on Crypto and Prediction Markets Instead of Saving

AGQ’s Backwardation Squeeze Could Trigger a Delivery Default That Whipsaws Silver

Monroe Merger Closes, but Dividend Cut Signals Deeper Trouble Ahead

Health and Healthcare Articles

All Health and Healthcare Articles

4 Key Positive Biotech Stock Catalysts Coming Very Soon

4 Top Biotechs Expected to Beat Earnings Expectations

Why the Exelixis Cancer Trial News Matters This Time

Abbott, Mylan Join Forces to Dodge U.S. Taxes

UBS Very Bullish on Biotech Stocks Ahead of Second-Quarter Earnings

Breakthrough Blood Test in Identifying Alzheimer’s Disease

Upcoming Catalysts Could Drive Seven Biotech and Health Care Stocks Higher

Washington State Issues First Retail Marijuana Licenses

MannKind Poll Points to Bias That Stock Will Rise Above $15 into 2015

The Path to FDA Approval Could Launch Seven Biotech Stocks Much Higher

Poll: Where Does MannKind Stock Go in 2015 After Afrezza Approval?

Vindication for MannKind on FDA Approval

Two Health Care Stocks With 50% Upside Under Obamacare

MannKind’s Afrezza Inhaled Insulin Drug Gets FDA Approval

The Real Attraction to Vertex After Cystic Fibrosis Success

AGQ’s Backwardation Squeeze Could Trigger a Delivery Default That Whipsaws Silver

Monroe Merger Closes, but Dividend Cut Signals Deeper Trouble Ahead

Ditch Starbucks and DoorDash, George Kamel Says. How Cheap Appliances Can Replace Your Takeout Budget

Featured Reads

Ditch Starbucks and DoorDash, George Kamel Says. How Cheap Appliances Can Replace Your Takeout Budget

39% of Americans Are Betting on Crypto and Prediction Markets Instead of Saving